Old Web
English
Sign In
Acemap
>
authorDetail
>
Camms Investigators
Camms Investigators
Alemtuzumab
Internal medicine
Medicine
Pathology
Diabetes mellitus
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.
2020
Dana Horakova
Aaron Boster
Antonio Bertolotto
Mark S. Freedman
Isabel Firmino
Steven Cavalier
Alan Jacobs
Karthinathan Thangavelu
Nadia Daizadeh
Elizabeth Poole
Darren P. Baker
David Margolin
Tjalf Ziemssen
Camms Investigators
Show All
Source
Cite
Save
Citations (2)
THUR 177 Efficacy of alemtuzumab retreatment after 2 initial courses
2018
Journal of Neurology, Neurosurgery, and Psychiatry
Sharrack Basil
Singer Barry
Boster Aaron
Bass Ann
Berkovich Regina
Comi Giancarlo
Fernández Óscar
Kim Ho-Jin
Limmroth Volker
Camms Investigators
Show All
Source
Cite
Save
Citations (0)
054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension
2018
Journal of Neurology, Neurosurgery, and Psychiatry
Richard Al Macdonell
Rany A Aburashed
Raed Alroughani
Dominique Dive
Guillermo Izquierdo
Ho-Jin Kim
Jan Lycke
Carlo Pozzilli
Basil Sharrack
Patrick Vermersch
Heinz Wiendl
Andreas Lysandropoulos
Luke Chung
Nadia Daizadeh
Samuel F. Hunter
Camms Investigators
Show All
Source
Cite
Save
Citations (0)
1